KRAS G12D inhibitor 3 TFA structure
|
Common Name | KRAS G12D inhibitor 3 TFA | ||
|---|---|---|---|---|
| CAS Number | 2757095-12-6 | Molecular Weight | 748.11 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H32ClF6N5O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS G12D inhibitor 3 TFAKRAS G12D inhibitor 3 TFA is a KRAS G12D inhibitor with an IC50 of <500 nM. KRAS G12D inhibitor 3 TFA has antitumor effects (WO2022002102A1; compound 146)[1]. |
| Name | KRAS G12D inhibitor 3 TFA |
|---|
| Description | KRAS G12D inhibitor 3 TFA is a KRAS G12D inhibitor with an IC50 of <500 nM. KRAS G12D inhibitor 3 TFA has antitumor effects (WO2022002102A1; compound 146)[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12D:<500 nM (IC50) |
| References |
[1]. Xing DAI, et al. Quinazoline compounds, preparation methods and uses thereof. WO2022002102A1. |
| Molecular Formula | C36H32ClF6N5O4 |
|---|---|
| Molecular Weight | 748.11 |